Senior Director, Access Strategy & Marketing

Revolution Medicines

1d•$232,000 - $290,000•Hybrid

About The Position

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director of Access Strategy & Marketing will lead the development and execution of access strategy, non-clinical positioning, and marketing materials for the RevMed portfolio with a focus on NSCLC. As the RevMed portfolio grows, the Senior Director will build, coach and manage a team of Access Marketers. This role will focus on developing the short to medium term non-clinical value proposition across payers, HCPs, organized customers (GPOs, IDNs, etc) and channel partners. This role will be instrumental in supporting a successful launch through leading launch planning across Market Access function, tailored messaging to various customer types, and working cross-functionally with Brand Marketing, Medical/HEOR, Regulatory and Compliance partners. This role will require ability to educate and influence various senior-level stakeholders on Market Access strategy, key decisions and implications. The ideal candidate will also have experience in translating a dynamic policy and reimbursement landscape into access strategies over the product lifecycle (ie, impact of IRA, MFN, etc). This position is based out of our headquarters in Redwood City, CA. Remote candidates may be considered on case by case basis.

Requirements

Bachelor’s degree required with 12+ years of experience in managed care strategy and marketing.
Experience in new product launches, including both high level strategy development and tactical execution.
Strong understanding of access landscape across all market access stakeholders.
Prior experience with developing co-positioning strategy across multiple assets and identifying portfolio tradeoffs.
Track record of being an inspiring leader and coach.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication.
Ability to travel up to 25%.

Nice To Haves

15+ years of experience in Marketing and/or Managed Care.
Oral Oncolytic product experience strongly preferred.
Deep understanding of US public policy and reimbursement dynamics.
Prior experience working with lifecycle and regulatory teams.
Prior experience in customer-facing roles.

Responsibilities

Develop and align with cross-functional partners on the three-year access strategy across RevMed’s NSCLC portfolio.
Lead and coach team of Access Marketers.
Coordinate launch readiness efforts across Market Access team and represent Market Access in senior-level forums (i.e., cross-functional launch planning, labelling team, etc).
Lead the creation of value proposition messaging and materials tailored for payers, PBMs, IDNs, GPOs, channel partners, and other key managed care decision-makers.
Develop strong relationship with Medical Affairs to inform data strategy and evidence generation plan.
Partner with national account field team to inform strategy and materials development.
Work closely with Brand Marketing, Regulatory and Compliance to ensure all materials support brand goals and follow compliance guidelines.